
To begin
an activity,
click
the title of the program you wish to view.
The
goal of this educational activity is to increase
awareness of the role of blood glucose monitoring
in the management of diabetes and to provide
information that will improve the prognosis
of patients with diabetes
This
educational activity is designed for pharmacists,
nurses, and dietitians who are involved with
patient education and counseling
-
-
Registered
Nurses: 1.5 contact hours
-
Dietitians:
1.0 Continuing Professional Education
Unit
Management
of Hemophilia and Other Bleeding Disorders
Click on The Title to Enter the Activity
This
educational program provides pharmacists and nurses
with a review of the pathophysiology of hemophilia
and other bleeding disorders as well as an update
on the newest treatment options available.
Included
in this program is a description of the deficiencies
in the coagulation cascade that affect patients
with hemophilia A or B, and a discussion of inhibitor
development and how inhibitors are diagnosed. Additionally,
information is provided on current treatment options
for hemophilia as well as for other bleeding disorders.
This
continuing education activity is provided by an
unrestricted educational grant from Novo Nordisk
Pharmaceuticals, Inc.
This
activity offers CE credit for pharmacists and registered
nurses.
-
-
Registered
Nurses: 1.8 contact hours
The
choice of insulin delivery systems is currently
quite broad, with new options under development.
Knowledge of the available and potential future
options for insulin delivery is important for
all members of the diabetes management team.
This
monograph will provide pharmacists and nurses
with information on the importance of glycemic
control and knowledge of a variety of methods
of insulin delivery so that they may guide patients
with diabetes in selecting the most suitable
delivery method.
This
continuing education activity is provided by
an unrestricted educational grant from Novo
Nordisk Pharmaceuticals, Inc.
This
activity offers CE credit for pharmacists and
registered nurses.
-
-
Registered
Nurses: 1.2 contact hours
Diabetic
Ketoacidosis in the Adult Patient
Click on The Title to Enter the Activity
DKA
is a life-threatening complication of diabetes that
is caused by relative or absolute insulin deficiency,
which results in hyperglycemia, ketonemia, dehydration,
electrolyte imbalances, and acidosis. Treatment
protocols for adults generally advocate a more rapid
and aggressive reversal of DKA than is advised for
children. DKA consumes a significant proportion
of all direct medical costs for adults and children
with type 1 diabetes. The management of DKA requires
a full complement of hospital, emergency, and intensive
care services. In the United States, more than 100,000
individuals are hospitalized each year for DKA and
the mortality rate is 2% to 5%.
Most
cases of DKA can be prevented by using an effective
diabetes management plan that includes patient self-care.
Early identification of precipitating signs and
symptoms and prompt, appropriate intervention can
reduce the frequency of DKA episodes that result
in a medical emergency.
The
healthcare team must stay informed about the recent
developments in diabetes care and have the necessary
clinical skills to prevent and manage DKA episodes.
Through good self-management and intensive glycemic
control, the incidence, morbidity, and mortality
of DKA can be reduced.
This
continuing education activity is provided by an
unrestricted educational grant from Novo Nordisk
Pharmaceuticals, Inc.
This
activity offers CE credit for pharmacists and registered
nurses.
-
-
Registered
Nurses: 2.8 contact hours
This
activity is designed to enhance the healthcare
professional's knowledge and understanding of
the management of growth hormone deficiency in
children. It is intended for pharmacists, nurses,
and certified case managers who work with children
referred for evaluation and treatment of short
stature. In addition to a review of the structure,
regulation and physiologic actions of growth hormone,
this program will describe the diagnosis and treatment
of growth hormone deficiency.
This
continuing education activity is supported by
an unrestricted educational grant from Novo Nordisk
Pharmaceuticals, Inc.
This
activity offers CE credit for pharmacists, nurses,
and case managers.
Insulin
Delivery Systems
Click on The Title to Enter the Activity
This
activity is designed to enhance the healthcare professional's
knowledge and understanding of insulin delivery systems
in the management of diabetes. It is intended for
pharmacists, nurses, and dietitians who work with
or anticipate working with patients with diabetes
who may require insulin. Discussed in the activity
are a review of key findings of the Diabetes Control
and Complications Trial and the United Kingdom Prospective
Diabetes Study; current options for insulin delivery;
a comparison of traditional vial and syringe insulin
administration to other insulin delivery systems;
and insulin delivery systems in research and development.
This
continuing education activity is supported by an unrestricted
educational grant from Novo Nordisk Pharmaceuticals,
Inc.
This
activity offers CE credit for pharmacists, nurses,
and dietitians:
-
-
Registered
Nurses: 1.2 contact hours
-
Dietitians:
1.0 CPEUs
This
continuing education monograph is designed for nurses
and pharmacists who treat patients with diabetes and
wish to expand their knowledge of insulin therapy
and continuous subcutaneous insulin infusion (CSII).
Described
in the activity are the basic mechanism of CSII therapy,
the intent and indications, and the process for selecting,
training, and initiating patients to CSII therapy.
Also discussed are the risks and benefits associated
with CSII therapy, the types of insulin used, and
the material, financial, and psychosocial resources
necessary for successful CSII therapy.
This
continuing education activity is supported by an unrestricted
educational grant from Novo Nordisk Pharmaceuticals,
Inc.
This
activity offers CE credit for pharmacists:
Managing
Diabetes with Oral Antidiabetic Agents
This
activity is designed to enhance the healthcare professional's
knowledge and understanding of treatment options that
may be considered when implementing oral medications
in the stepped care approach to type 2 diabetes. It
is intended for pharmacists, nurses, and dietitians
who are involved in the education and counseling of
patients with type 2 diabetes.
Discussed
in the activity are special considerations to review
with the patient who is taking oral antidiabetic medications
and the mechanism of action of oral medications available
to treat type 2 diabetes.
This
program is supported through an unrestricted educational
grant from Novo Nordisk Pharmaceuticals, Inc.
This
activity offers CE credit for pharmacists, nurses,
and dietitians:
This
monograph has been designed to enhance the healthcare
professional's knowledge and understanding of new
insulin products and diabetes treatment strategies.
It is intended for pharmacists and dietitians who
work with or anticipate working with patients with
diabetes who may require insulin.
Discussed
in the program are the impact of the disease, insulin
formulations, insulin analogs, dosing regimens, and
available alternatives for insulin administration.
The benefits of tight glycemic control and techniques
for minimizing problems associated with insulin therapy
are identified and described.
This
program is supported through an unrestricted educational
grant from Novo Nordisk Pharmaceuticals, Inc.
This
activity offers CE credit for pharmacists:

|
|
 |
|